STE vs ZBH — Key Metrics
| Metric | STE (STERIS PLC) | ZBH (ZIMMER BIOMET HOLDINGS INC) |
|---|---|---|
| Price | 259.57 | 103.32 |
| Market Cap | 25.21 Billion | 19.55 Billion |
| P/E (TTM) | 30.68 | 26.03 |
| P/B (Quarterly) | 3.4 | 1.639 |
| P/S (TTM) | 4.09 | 2.28 |
| Net Profit Margin (TTM) | 13.4 | 9.0 |
| Gross Margin (TTM) | 44.6 | 69.7 |
| ROE (TTM) | 11.5 | 6.1 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Underperform
Recommendation Summary
Stock STE is projected to greatly underperform the market, stock ZBH is projected to underperform the market. Upfront Recommendation: ZBH.
Financial Metrics
| STE | Metrics | ZBH |
|---|---|---|
| $259.57 | Price | $103.32 |
| — | Market Capitalization | — |
| 30.68 | Price to Earnings Ratio | 26.03 |
| 4.09 | Price to Sales | 2.28 |
| 26.6 | Price to FCF Ratio | 15.1 |
| 9.17 | Price to Gross Profit | 3.27 |
| 212.89 | Price to R&D | 45.18 |
| 10.17 | Price to Current Assets | 3.81 |
STE vs ZBH at a glance
Steris PLC (STE) and Zimmer Biomet Holdings INC (ZBH) are both Medical Devices companies in the Healthcare sector. STE is the larger, at $25.2 billion in market value against $19.6 billion for ZBH, about 1.3 times the size.
On trailing-twelve-month figures, STE trades at 30.7 times trailing earnings and ZBH at 26.0; net profit margins are 13.4% and 9.0%.
The Upfront Investment model currently rates STE Greatly Underperform and ZBH Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.